Literature DB >> 18473768

The pathogenic role of intestinal flora in IBD and colon cancer.

Maria Rescigno1.   

Abstract

The intestine is populated by a large variety of microorganisms that colonize the host soon after birth. The gut microflora contributes to several intestinal functions, including the development of the mucosal immune system, the absorption of complex macromolecules, the synthesis of amino acids and vitamins and the protection against pathogenic microorganisms. Its composition varies along the different segments of the gut, with a gradient from the stomach to the colon where it is more abundant. Given the vital relationship between the microflora and the intestinal function, it is important that the microflora is kept continuously under control so to preserve gut homeostasis. When this is not achieved or perturbed, several immune disorders can arise, like allergies or inflammation. Protracted immune deregulations can also lead to severe disorders including diabetes, cancer and inflammatory bowel disease (IBD). It is therefore crucial that the immune system learns both to tolerate and to control the growth of beneficial microorganisms so to preserve the intestinal homeostasis. The mechanisms that are in place to achieve this control are not yet understood but recent work has started to unravel the complex relationship between several players including the microflora, intestinal barriers and immune cells. In this review we will analyze how the microflora interacts with the host and how deregulation of this interaction can lead to inflammatory disorders and eventually also to cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18473768     DOI: 10.2174/138945008784221125

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  15 in total

Review 1.  Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.

Authors:  Kristi Baker; Shuo-Wang Qiao; Timothy Kuo; Kanna Kobayashi; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

Review 2.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

3.  Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients.

Authors:  Annemarie Boleij; Rian Roelofs; Renée M J Schaeps; Tanja Schülin; Philippe Glaser; Dorine W Swinkels; Ikuko Kato; Harold Tjalsma
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

4.  Additional prognostic factors in right colon cancer staging.

Authors:  Domenico Parmeggiani; Nicola Avenia; Adelmo Gubitosi; Francesco Gilio; Pietro Francesco Atelli; Massimo Agresti
Journal:  Updates Surg       Date:  2011-06-23

Review 5.  Role of bone marrow-derived cells in colon cancer: lessons from mouse model studies.

Authors:  Makoto Mark Taketo
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

6.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing.

Authors:  Geethanjali Pickert; Clemens Neufert; Moritz Leppkes; Yan Zheng; Nadine Wittkopf; Moritz Warntjen; Hans-Anton Lehr; Sebastian Hirth; Benno Weigmann; Stefan Wirtz; Wenjun Ouyang; Markus F Neurath; Christoph Becker
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

7.  Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.

Authors:  Erika Mileti; Gianluca Matteoli; Iliyan D Iliev; Maria Rescigno
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

8.  Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity.

Authors:  Mitsuko L Yamamoto; Irene Maier; Angeline Tilly Dang; David Berry; Jared Liu; Paul M Ruegger; Jiue-In Yang; Phillip A Soto; Laura L Presley; Ramune Reliene; Aya M Westbrook; Bo Wei; Alexander Loy; Christopher Chang; Jonathan Braun; James Borneman; Robert H Schiestl
Journal:  Cancer Res       Date:  2013-07-15       Impact factor: 12.701

Review 9.  The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Fatimah Abu Bakar
Journal:  J Exp Clin Cancer Res       Date:  2011-01-20

10.  High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD.

Authors:  Alberto J León; Emma Gómez; Jose A Garrote; David Bernardo; Asterio Barrera; Jose L Marcos; Luis Fernández-Salazar; Benito Velayos; Alfredo Blanco-Quirós; Eduardo Arranz
Journal:  Mediators Inflamm       Date:  2009-07-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.